MeSH tree: D12.644.024
When a person goes into deep sleep, waterlike fluid circulates around the brain, washing away metabolic waste that is linked to diseases such as Alzheimer's. This process, known as the glymphatic system, was first described ...
May 27, 2026
0
43
Why are conditions such as chronic stress, depression, cardiovascular disease, fragmented sleep, and aging all associated with a higher risk of dementia? In a new review piece in Science, University of Rochester Medicine ...
May 21, 2026
0
28
For the first time, therapeutically effective medications are now available for Alzheimer's disease. Effective symptomatic therapies also exist for Parkinson's disease; however, a prerequisite for successful treatment is ...
May 21, 2026
0
9
A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the drugs work, according to a new study led by researchers at the Brown University School of Public Health.
May 18, 2026
0
16
A new study offers fresh insight into Alzheimer's disease by looking beyond the brain and focusing on metabolic health, particularly obesity. The Houston Methodist-led study moves beyond the traditional view of obesity as ...
May 11, 2026
0
14
Subtle biological changes linked to Alzheimer's disease may begin as early as the late 50s—decades before memory loss or other symptoms appear—according to new research from Mayo Clinic.
Apr 28, 2026
0
11
A research team has, for the first time, identified at the cellular level why the olfactory system is the first to be damaged in the early stages of Alzheimer's disease (dementia). The paper is published in the journal Alzheimer's ...
Apr 26, 2026
0
6
Researchers have found evidence that a therapeutic strategy which makes the brain work more efficiently to learn and recall memories may in fact help to target compromised brain activity in Alzheimer's disease. The study ...
Apr 21, 2026
0
15
Drugs once hailed as a breakthrough in the fight against Alzheimer's disease do not meaningfully help patients, a major review found Thursday, however some experts criticized the research.
Apr 16, 2026
0
16
Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing the risk of bleeding and swelling in the brain, a new review in the Cochrane Database of Systematic ...
Apr 15, 2026
0
10
